SpringWorks Therapeutics, Inc.

NASDAQ:SWTX

35.35 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -325.104-277.417-173.91-45.574-58.306-17.813-4.639
Depreciation & Amortization 1.6670.7650.490.3490.1920.0170.003
Deferred Income Tax 9.22900.9880.605000
Stock Based Compensation 94.53472.96538.44410.0343.1091.0690
Change In Working Capital -0.58338.1035.1181.3464.9472.0210.383
Accounts Receivables -5.93000000
Inventory -3.103000000
Accounts Payables -0.1964.1682.074-1.3041.880.4910.283
Other Working Capital 9.22933.9353.0442.653.0671.530.1
Other Non Cash Items -2.5384.0210.9931.0492.6140.6121.737
Operating Cash Flow -222.795-161.563-127.877-32.191-47.444-14.706-2.239
Investing Activities:
Investments In Property Plant And Equipment -7.385-10.196-2.016-0.642-0.67-0.293-0.044
Acquisitions Net -2.8-4.22.016-3.5-3.5900
Purchases Of Investments -575.724-481.05-305.423-442.69-3.5900
Sales Maturities Of Investments 620.663279.849391.031283.59400
Other Investing Activites 42.139-205.401-2.016-418.19-0.00400
Investing Cash Flow 34.754-215.59783.592-418.832-4.26-0.293-0.044
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 299.3342.0431.157269.592169.7350.37612.554
Common Stock Repurchased -2.8-1.34100000
Dividends Paid 0000000
Other Financing Activities 0.139342.0430.0010.893163.97850.37637.662
Financing Cash Flow 296.639340.7021.157270.485333.70850.37612.554
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 108.598-36.458-43.128-180.538282.00435.37710.271
Cash At End Of Period 176.66668.068104.526147.654328.19245.64810.271